Drug

Who makes levothyroxine sodium anhydrous?

6 companies list levothyroxine sodium anhydrous as a human prescription drug. Forms: injection, powder, lyophilized, for solution. Routes: intravenous.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing levothyroxine sodium anhydrous

CompanyFormsApplicationNDCsRegistered sites
Fresenius Kabi USA, LLCUnited Statesinjection, powder, lyophilized, for solutionNDANDA20223136
Endo USA, Inc.United Statesinjection, powder, lyophilized, for solutionNDANDA20223133
ONESOURCE SPECIALTY PHARMA LIMITEDIndiainjection, powder, lyophilized, for solutionANDAANDA21672933
MAIA Pharmaceuticals, Inc.injection, powder, lyophilized, for solutionANDAANDA20874930
Sagent Pharmaceuticalsinjection, powder, lyophilized, for solutionANDAANDA20874930
Fosun Pharma USA Inc.injection, powder, lyophilized, for solutionANDAANDA21672910
Enquiry

Common questions

Who makes levothyroxine sodium anhydrous?
6 companies list levothyroxine sodium anhydrous as a human prescription drug in the openFDA NDC Directory, led by Fresenius Kabi USA, LLC, Endo USA, Inc., ONESOURCE SPECIALTY PHARMA LIMITED, MAIA Pharmaceuticals, Inc., Sagent Pharmaceuticals. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Is there a generic levothyroxine sodium anhydrous?
4 companies list levothyroxine sodium anhydrous under an abbreviated new drug application (ANDA), the application type used for generics, and 2 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.